- Home
- ELMD vs PRQR Comparison
ELMD vs PRQR Comparison
Compare ELMD & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- PRQR
- Stock Information
- Founded
- ELMD 1992
- PRQR 2012
- Country
- ELMD United States
- PRQR Netherlands
- Employees
- ELMD N/A
- PRQR N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- PRQR Health Care
- Exchange
- ELMD Nasdaq
- PRQR Nasdaq
- Market Cap
- ELMD 206.5M
- PRQR 232.8M
- IPO Year
- ELMD 2010
- PRQR 2014
- Fundamental
- Price
- ELMD $24.59
- PRQR $1.99
- Analyst Decision
- ELMD Strong Buy
- PRQR Strong Buy
- Analyst Count
- ELMD 2
- PRQR 8
- Target Price
- ELMD $35.50
- PRQR $8.88
- AVG Volume (30 Days)
- ELMD 98.8K
- PRQR 378.7K
- Earning Date
- ELMD 11-11-2025
- PRQR 11-06-2025
- Dividend Yield
- ELMD N/A
- PRQR N/A
- EPS Growth
- ELMD 46.55
- PRQR N/A
- EPS
- ELMD 0.85
- PRQR N/A
- Revenue
- ELMD $64,000,000.00
- PRQR $20,129,184.00
- Revenue This Year
- ELMD $14.47
- PRQR N/A
- Revenue Next Year
- ELMD $10.33
- PRQR N/A
- P/E Ratio
- ELMD $28.81
- PRQR N/A
- Revenue Growth
- ELMD 16.97
- PRQR 8.65
- 52 Week Low
- ELMD $17.73
- PRQR $1.07
- 52 Week High
- ELMD $35.56
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- ELMD 58.45
- PRQR 37.36
- Support Level
- ELMD $23.75
- PRQR $2.21
- Resistance Level
- ELMD $26.95
- PRQR $2.50
- Average True Range (ATR)
- ELMD 1.29
- PRQR 0.15
- MACD
- ELMD 0.01
- PRQR -0.03
- Stochastic Oscillator
- ELMD 66.38
- PRQR 4.63
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.